The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Of­ten-passed plant in Col­orado has a new own­er, who's al­ready op­er­at­ing near­by

4 years ago
R&D

Mo­roc­can gov­ern­ment drops $500M in­to new Re­ci­pharm fill-fin­ish plant in big boost for African man­u­fac­tur­ing

4 years ago
Outsourcing

Re­call re­port: Teva's chemother­a­py drug re­called af­ter in­ves­ti­ga­tors find par­tic­u­lates in­side vials

4 years ago

Agenus to move Cal­i­for­nia op­er­a­tions to new bio­man­u­fac­tur­ing clus­ter in Va­cav­ille

4 years ago

FDA hands a warn­ing let­ter to a Lupin sub­sidiary af­ter fail­ing to main­tain clean­li­ness once again

4 years ago
Outsourcing

Covid-19 man­u­fac­tur­ing roundup: In a push to vac­ci­nate Asia, South Ko­rea ready to make 1B vac­cine avail­able; Mex­i­co's im­ports of Pfiz­er's jab re­duced tem­porar­i­ly

4 years ago
Coronavirus

BioN­Tech and Takara en­ter li­cense agree­ment for CAR-T; The FDA has freed an­oth­er batch of J&J's Covid-19 vac­cine

4 years ago

In­ter­view with Phlow CEO: How soon will es­sen­tial drug man­u­fac­tur­ing come to the US?

4 years ago

Af­ter de­lay caused by Ital­ian CD­MO, No­var­tis moves man­u­fac­tur­ing to Aus­tri­an site

4 years ago
R&D

Woes con­tin­ue pil­ing up for Emer­gent as man­u­fac­tur­er faces in­vestor re­volt, in­sid­er trad­ing al­le­ga­tions

4 years ago
Coronavirus

Years af­ter bank­rupt­cy, Den­dreon adds a con­tract man­u­fac­tur­ing wing

4 years ago
Outsourcing

Covid-19 man­u­fac­tur­ing roundup: In­dia starts man­u­fac­tur­ing of No­vavax vac­cine — re­port; US ships spare shots to Colom­bia

4 years ago
Coronavirus

WuXi will add 500 jobs at Delaware man­u­fac­tur­ing cam­pus as it looks to bol­ster its CD­MO arm

4 years ago
Outsourcing

Catal­ent bags a Ger­man stem cell de­vel­op­er to build its next-gen ther­a­peu­tics wing

4 years ago
R&D
Outsourcing

A vi­ral vec­tor play­er is ex­pand­ing its foot­print in Basque Coun­try amid height­ened de­mand

4 years ago
Outsourcing

Fu­ji­film out­lays whop­ping $850M for its Diosynth CM­DO wing, look­ing to rapid­ly scale cell cul­ture pro­duc­tion

4 years ago
Outsourcing

Hori­zon takes the leap in­to man­u­fac­tur­ing, buy­ing out an Irish plant with around 40 em­ploy­ees in tow

4 years ago
Outsourcing

An In­di­ana CD­MO with big-name clients sets up plans for lentivi­ral pro­duc­tion site

4 years ago
Outsourcing

Am­gen adds 400 jobs in cen­tral Ohio as part of an ex­pan­sion of its pack­ag­ing op­er­a­tions

4 years ago

Sanofi in­vests in the fu­ture of mR­NA with plan to pump bil­lions of dol­lars in­to next-gen cell ther­a­py busi­ness

4 years ago
R&D
Cell/Gene Tx

Re­call re­port: Pfiz­er puts a stop on Chan­tix dis­tri­b­u­tion af­ter traces of pos­si­ble car­cino­gens found

4 years ago

With the ground bro­ken on a Van­cou­ver head­quar­ters, an­ti­body mak­er Ab­Cellera will add man­u­fac­tur­ing space next door

4 years ago

Emer­gen­t's bad year con­tin­ues with House over­sight com­mit­tee de­mand­ing doc­u­ments tied to vac­cine screwup

4 years ago

J&J, Leg­end un­veil plans for Bel­gian cell ther­a­py man­u­fac­tur­ing fa­cil­i­ty as the part­ners await ap­proval for lead drug

4 years ago
First page Previous page 68697071727374 Next page Last page
A service from the Financial Times